Our CTO, Niklas Sandler, and Head of AI, Jukka Corander, were interviewed by Contract Pharma to discuss the application of AI for enhanced drug particle engineering.
At the Bio-Europe Spring meeting, our CCO, Christian Jones, discusses how we use physics to enhance drug discovery and development for our partners in the pharmaceutical industry.